Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Biogerontology|August 17, 2013
Lipidomics in longevity and healthy agingVanessa Gonzalez-Covarrubias
Pharmaceutical Research|May 2, 2008
Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER)Vanessa Gonzalez-Covarrubias, James L Kalabus, Javier G Blanco
Metabolites|February 25, 2022
The Potential of Metabolomics in Biomedical ApplicationsVanessa Gonzalez-Covarrubias, Eduardo Martínez-Martínez, Laura Del Bosque-Plata
Journal of Personalized Medicine|September 28, 2023
Pharmacogenetic Variants Associated with Fluoxetine Pharmacokinetics from a Bioequivalence Study in Healthy SubjectsCarlos Alejandro Díaz-Tufinio, José Antonio Palma-Aguirre, Vanessa Gonzalez-Covarrubias
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 9, 2007
A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinityVanessa Gonzalez-Covarrubias, Debashis Ghosh, Sukhwinder S Lakhman, et al.
Molecular Pharmacology|June 16, 2007
Functional characterization of the promoter of human carbonyl reductase 1 (CBR1). Role of XRE elements in mediating the induction of CBR1 by ligands of the aryl hydrocarbon receptorSukhwinder S Lakhman, Xiaomin Chen, Vanessa Gonzalez-Covarrubias, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2008
Pharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donorsVanessa Gonzalez-Covarrubias, Jianping Zhang, James L Kalabus, et al.
Toxicology Letters|February 16, 2006
Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whitesVanessa Gonzalez Covarrubias, Sukhwinder S Lakhman, Alan Forrest, et al.
Gene|January 7, 2015
Genotype frequencies of VKORC1 and CYP2C9 in native and Mestizo populations from Mexico, potential impact for coumarin dosingBeatriz Villegas-Torres, Francisco Sánchez-Girón, Karla Jaramillo-Villafuerte, et al.
Pharmacological Reports : PR|June 6, 2021
Genotyping NUDT15*3 rs1166855232 reveals higher frequency of potential adverse effects of thiopurines in Natives and Mestizos from MexicoTomas Texis, Cintia Guzmán-Cruz, Mauricio Rodríguez-Dorantes, et al.
Pageof 3